1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.

Slides:



Advertisements
Similar presentations
Overview of Health System Strengthening
Advertisements

Strengthening the Pharmaceutical Sector: Mechanisms to Monitor Performance Douglas L. Keene June 15, 2010.
Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
Elizabeth Lule Manager ACTafrica The World Banks response to HIV/AIDS in Africa: MAP High Level Dialogue on Maximizing Synergies between Health Systems.
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Impact of Large-Scale Infant Feeding Promotion on Child Survival and Health in Madagascar.
New Technologies for Tuberculosis Control: Programme Perspective Draft Definitions Retooling Task Force Meeting Geneva, Switzerland January 2008.
The Global Laboratory Initiative Assisting countries to implement the WHA resolution on MDR-TB Karin Weyer, WHO-STB, GLI secretariat John Ridderhof, CDC,
World Health Organization
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
CCIH Annual Conference May 24-26, 2008 World Bank Roles, Issues Katherine Marshall 1.
EU and Wider Neighborhood Ukraine. EU and Wider Neighborhood Health Gap Main problem –premature adult morbidity and mortality Economic issue –loss of.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
USAID Update 2014 Bureau for Global Health Christine Malati, PharmD
1 Collective Efficiencies Development Finance Architecture Workshop Prerna Banati - July
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Generating evidence for change: Implementing the post-ICIUM research agenda Dennis Ross-Degnan, ScD Harvard Medical School and Harvard Pilgrim Health Care.
THE NEED FOR ADVOCACY & PROMOTING EYE HEALTH IN INDIA Thulasiraj Ravilla LAICO – Aravind Eye Care System.
Process of Development of Five Year Strategic Plan for Child Health Development Dr Myint Myint Than Deputy Director (WCHD) Department of Health.
Importance of Health Information Systems Information explosion during 1990s  It is estimated that in the next 50 years, the amount of knowledge currently.
Total health ODA commitments, US$ Billions.
HIV Therapy for the Developing World: A Global Health Challenge Harold W. Jaffe, MD Department of Public Health University of Oxford Oxford, UK.
Country Ownership of National HIV & AIDS Response: A Private Sector Perspective Country Ownership of National HIV & AIDS Response: A Private Sector Perspective.
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.
Svetlana Spassova, MD Ministry of Health, Bulgaria Chisinau
Pharmaceutical system strengthening – Is there a need for a new paradigm? Andreas Seiter The World Bank ICIUM 2011, Antalya 1.
Governance of AIDS Response UNDP HIV/AIDS Group, BDP Moscow, June 6, 2007.
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
Towards Universal Access Scaling up HIV Prevention, Treatment, Care and Support: The Role of the United Nations.
Existing Challenges – POC Introduction Lab Technical Working Group Jason Williams, Principal Laboratory Advisor, SCMS January 20-21, 2013.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
CPM Programs1. 2 Center for Pharmaceutical Management Programs James Rankin.
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
BASELINE SURVEYS AND MONITORING OF PHARMACEUTICAL SITUATION IN COUNTRIES. Joseph Serutoke NPO/EDM WHO Uganda November 2002.
Setting Standards for Health Statistics: The HMN Framework High Level Forum on Strategic Planning for Statistics Bangkok 6-9 June
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
The Next Stage for Results in Africa. Context 2005 Paris Declaration on Aid Effectiveness 2006 Mutual Learning Events Uganda & Burkina Faso 2007 Hanoi.
Ministry of Healthcare & Nutrition Broader Approaches to Health Strategic Frame Work for Health Development.
WHO/OMS Improving and increasing investments in the health outcomes of the poor Macroeconomics and Health in context Dr. Sergio Spinaci, WHO Senegal, February.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Financing for Reproductive, Mother, Newborn, Child, and Adolescent Health for UHC ACCELERATING PROGRESS ON EARLY ESSENTIAL NEWBORN CARE September,
PEPFAR The Global Fund and PEPFAR: Strategic Collaboration for Greater Impact Mark Edington, Director, Grants Management, Global Fund Julia Martin, Chief.
Global Partnership for Enhanced Social Accountability (GPESA) December 19, 2011 World Bank.
Encouraging Country-Led Strategies to Ensure Contraceptive Security in Ghana International Conference on Family Planning Addis Ababa, Ethiopia 14 November.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
The Bank’s Regional HIV/AIDS Strategies An Overview.
1 Center Mission Statements SAMHSA ? CSAT Improving the Health of the Nation by Bringing Effective Alcohol and Drug Treatment to Every Community CMHS Caring.
SPECIAL SESSION COUNTDOWN TO 2015 IN ETHIOPIA SIX BUILDING BLOCKS OF THE HEALTH SYSTEM: PROGRESS TOWARDS THE INTEGRATION IN ETHIOPIA Dereje Mamo Tsegaye.
Palestinian Health Sector Reform And Development Project “The Flagship Project” The Palestinian Health Conference “Toward Quality and Sustainable Health.
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Strategic Information on ART Scale up Kevin O'Reilly Department of HIV/AIDS WHO.
Towards a National eHealth Strategy Regional Symposium on E-government and IP Dubai - UAE November 2004.
National Health Strategy
Selected events related to the treatment of AIDS
Expanding ARV treatment in developing countries: Issues and Prospects
PRIVATE AND THE PUBLIC SECTORS & HEALTHCARE SERVICES BY ROBERT BASAZA
Access to HIV/AIDS Medicines The 3x5 strategy
National Medicines Policies
Access to Essential Medicines
Deliver Ethiopia 7/27/2019.
National Medicines Policies
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Presentation transcript:

1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011

2 Dimensions of Drug Supply

From Supply Management to Medicines Access

4 A New Paradigm FY 2000: Dimensions of Access

5 Estimated Total Annual Resources Available for AIDS, 1996 – 2005 PEPFAR Source: Lancet, 2006; 368: 526– World Bank MAP Launch Signing of Declaration of Commitment on HIV/AIDS Global Fund ( US$ millions ) USAID’s Millennium Challenge Account Global Alliance for Vaccines and Immunization Accelerating Access Initiative

6 Procurement of Drugs Overshadows Human Resources, Capacity, and Systems 48% Drugs Commodities Products etc... 6% Other 11% Infrastructure and Equipment 2% Monitoring and Evaluation 11% Administration 11% Tuberculosis

7 A Few Realities for Saving Lives and Improving Health Funding is never the only constraint and is often not the major constraint “Solving” the financing problem inevitably reveals other weaknesses Lasting impact depends on reliable health systems: – Strengthened systems – Management tools – Human resources – Capacity building

8 Center for Pharmaceutical Management

9 Working Definition of Pharmaceutical Services Pharmaceutical services include all services rendered by pharmaceutical staff to support the provision of patient care and treatment. Beyond the supply of pharmaceutical products, pharmaceutical services include educating and training of staff, providing medicine information and counseling in support of prescribing and dispensing practices, monitoring medicine use to assure patient safety and achieve desired health outcomes, formulating policies and regulation for improved pharmaceutical care, and disseminating information and educational materials to promote public health.

10 USAID Programs Regional Pharmaceutical Management Project [Eastern Caribbean Drug Service] – 1986 – 1990 Rational Pharmaceutical Management Project (RPM) – 1992 – 1999 Rational Pharmaceutical Management Plus Program (RPM Plus) – 2000 – 2007 Supply Chain Management Systems Project (SCMS) – 2013 Strengthening Pharmaceutical Systems Program (SPS) – 2007 – 2012 Systems for Improved Access to Pharmaceuticals and Services (SIAPS) – 2011 – 2016

11 Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Pharmaceutical System Strengthening Framework Analysis International health initiatives Local context Health status Health systems Evidence- based strategy Sustainable Health Outcomes and Impact aligned with: Country Strategic Plans and USG/USAID Health-Specific Results Monitor and Evaluate Performance Improved coverage & access of evidence- based interventions Government MOH, other ministries, regulators, policy makers Community patients, consumers, caregivers, civil society Providers public/private, NGO, commercial sector, professional associations Improved health system performance Governance InformationFinancing Service Delivery Human Resources Medical Products

12 SIAPS Core Operating Principles Build on and strengthen existing systems Support integration (of other public health programs and supply systems) Build the capacity of local organizations Support country-led coordination Continually monitor and evaluate Develop improved performance metrics Harmonize tools, approaches, and metrics Share knowledge and information

13